Presentation is loading. Please wait.

Presentation is loading. Please wait.

Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans.

Similar presentations


Presentation on theme: "Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans."— Presentation transcript:

1 Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry J Am Coll Cardiol. 2008;51(17):1675-1684. doi:10.1016/j.jacc.2008.01.028 Heart Failure Measures at Hospital Discharge Percent of patients who received heart failure measures at hospital discharge by race. ACE = angiotensin-converting enzyme; LVEF = left ventricular ejection fraction. Figure Legend:

2 Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry J Am Coll Cardiol. 2008;51(17):1675-1684. doi:10.1016/j.jacc.2008.01.028 Other Medications at Hospital Discharge Eligible patients receiving other medications at hospital discharge by race. *ACE inhibitor and/or ARB use in patients with left ventricular systolic dysfunction (LVSD), excluding patients with contraindications to ACE inhibitor and/or ARB. †Beta-blocker use in patients with LVSD, excluding patients with contraindications to beta-blocker drugs. ‡Statin use in patients with medical history of coronary artery disease, cerebral vascular accident/transient ischemic attack, diabetes, hyperlipidemia, or peripheral vascular disease. §Aldosterone antagonist, hydralazine, and nitrate use in patients with LVSD. ∥ Warfarin use in patients with chronic or paroxysmal atrial fibrillation. ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; HYDR/ISDN = hydralazine/isosorbide dinitrate. Figure Legend:

3 Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry J Am Coll Cardiol. 2008;51(17):1675-1684. doi:10.1016/j.jacc.2008.01.028 Outcomes in Patients With Left Ventricular Systolic Dysfunction (A) In-hospital outcomes in heart failure patients with left ventricular systolic dysfunction (LVSD) by race. (B) The 60- to 90-day post- discharge outcomes in heart failure patients with LVSD by race. Figure Legend:

4 Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry J Am Coll Cardiol. 2008;51(17):1675-1684. doi:10.1016/j.jacc.2008.01.028 Outcomes in Patients Without LVSD (A) In-hospital outcomes in heart failure patients without left ventricular systolic dysfunction (LVSD) by race. (B) The 60- to 90-day post-discharge outcomes in heart failure patients without LVSD by race. Figure Legend:


Download ppt "Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans."

Similar presentations


Ads by Google